An adjuvant-modulated vaccine response in human whole blood

References

• Godkin AJ, Thomas HC, Openshaw PJ. Evolution of epitope-specific memory CD4+ T cells after clearance of hepatitis C virus. J Immunol 2002; 169(4):2210-4; PMID:12165552; https://doi.org/10.4049/jimmunol.169.4.2210
   PubMed Web of Science ®Google Scholar
• Todryk SM, Pathan AA, Keating S, Porter DW, Berthoud T, Thompson F, Klenerman P, Hill AV. The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent distal priming. Immunology 2009; 128(1):83-91; PMID:19689738; https://doi.org/10.1111/j.1365-2567.2009.03073.x
   PubMed Web of Science ®Google Scholar
• Sullusto F, Lanzavecchia A, Araki K, Ahmed R. From vaccines to memory and back. Immunity 2010; 33(4):451-63; PMID:21029957; https://doi.org/10.1016/j.immuni.2010.10.008
   PubMed Web of Science ®Google Scholar
• Ahmed R, Grey D. Immunological memory and protective immunity: Understanding their rection. Science 1996; 272(5258):54-60; PMID:8600537; https://doi.org/10.1126/science.272.5258.54
   PubMed Web of Science ®Google Scholar
• Higbee RG, Byers AM, Dhir V, Drake D, Fahlenkamp HG, Gangur J, Kachurin A, Kachurina O, Leistritz D, Ma Y, et al. An immunologic model for rapid vaccine assessment - a clinical trial in a test tube. Altern Lab Anim 2009; 37(Supp 1):19-27; PMID:19807200
   PubMed Web of Science ®Google Scholar
• Junker B, Kosinski M, Geer D, Mahajan R, Chartrain M, Meyer B, Dephillips P, Wang Y, Henrickson F, Ezis K, et al. Design-for-six-sigma for development of a bioprocess quality-by-design framework. PDA J Pharm Sci Technol 2011; 65(3):254-86; PMID:22293236; https://doi.org/10.5731/pdajpst.2011.00739
   PubMedGoogle Scholar
• Geldenhuys H, Mearns H, Miles DJ, Tameris M, Hockey D, Shi Z, Bennet S, Andserson P, Kromann I, Hoff ST, et al. The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African males: A randomized controlled trial. Vaccine 2015; 33(30):3592-9; PMID:26048780; https://doi.org/10.1016/j.vaccine.2015.05.036
   PubMed Web of Science ®Google Scholar
• Sutherland JS, Lalor MK, Black GF, Ambrose LR, Loxton AG, Cheqou NN, Kassa D, Mihret A, Howe R, Mayanja-Kizza H, et al. Analysis of host responses to mycobacterium tuberculosis anitgens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa. PLoS One 2013; 8(9):e74080; PMID:24040170; https://doi.org/10.1371/journal.pone.0074080
   PubMed Web of Science ®Google Scholar
• Dockrell HM, Black GF, Weir RE, Fine PE. Whole blood assays for interfon-gamma: Practicalities and potential for use as diagnostic tests in the field. Lepr Rev 2000; 71(Suppl):S60-2; PMID:11201889
   PubMed Web of Science ®Google Scholar
• Aboutorabian S, Hakimi J, Boudet E, Montano S, Dookie A, Roque C, Ausar SE, Rahman N, Brookes RH. A high ratio of IC31 (R) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation. Hum Vaccin Immunother 2015; 11(6):1449-55; PMID:25997147; https://doi.org/10.1080/21645515.2015.1023970
   PubMed Web of Science ®Google Scholar
• Brookes RH, Hakimi J, Ha Y, Aboutorabian S, Ausar SE, Hasija M, Smith SG, Todryk SM, Dockrell HM, Rahman N. Screening vaccine formulations for biological activity using fresh human whole blood. Hum Vaccin Immunother 2014; 10(4):1129-35; PMID:24401565; https://doi.org/10.4161/hv.27657
   PubMed Web of Science ®Google Scholar
• Shen-Orr SS, Furman D, Kidd BA, Hadad F, Lovelace P, Juang YW, Rosenberg-Hasson Y, Mackey S, Grisar FA, Pickman Y, et al. Defective signaling in the JAK-STAT pathway tracks with chronic inflammation and cardiovascular risk in aging humans. Cell Syst 2016; 3(4):374-84.e4; PMID:27746093; https://doi.org/10.1016/j.cels.2016.09.009
   PubMed Web of Science ®Google Scholar
• Schellack C, Prinz K, Egyed A, Fritz JH, Wittmann B, Ginzler M, Swatosch G, Zauner W, Kast C, Akira S, et al. IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune response. Vaccine 2006; 24(26):5461-72; PMID:16678312; https://doi.org/10.1016/j.vaccine.2006.03.071
   PubMed Web of Science ®Google Scholar
• Hakimi J, Aboutorabian S, To F, Ausar SE, Rahman N, Brookes RH. Screening vaccine formulations in fresh whole human blood. Methods Mol Biol 2017; 1494:295-304; PMID:27718203; https://doi.org/10.1007/978-1-4939-6445-1_22
   PubMedGoogle Scholar
• Su LF, Han A, McGuire HM, Furman D, Newell EW, Davis MM. The promised land of human immunology. Cold Spring Harb Symp Quant Biol 2013; 78:203-13; PMID:24638855; https://doi.org/10.1101/sqb.2013.78.022905
   PubMedGoogle Scholar
• Montovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; 11(8):519-31; PMID:21785456; https://doi.org/10.1038/nri3024
   PubMed Web of Science ®Google Scholar
• Vono M, Lin A, Norby-Teglund A, Koup R, Liang F, Lore K. Neutrophils acquire antigen presentation capacity to memory CD4+ T cells in vitro and ex vivo. Blood 2017; 129(14):1991-2001; PMID:28143882; https://doi.org/10.1182/blood-2016-10-744441
   PubMed Web of Science ®Google Scholar
• O'Gorman WE, Huang H, Wei YL, Davis KL, Leipold MD, Bendall SC, Kidd BA, Dekker CL, Maecker HT, Chien YH, et al. The split virus influenza vaccine rapidly activates immune cells through Fcy receptors. Vaccine 2014; 32(45):5989-97; PMID:25203448; https://doi.org/10.1016/j.vaccine.2014.07.115
   PubMed Web of Science ®Google Scholar
• Saadatian-Elahi M, Aaby P, Shann F, Netea MG, Levy O, Louis J, Picot V, Greenberg M, Warren W. Heterologous vaccine effects. Vaccine 2016; 34(34):3923-30; PMID:27312214; https://doi.org/10.1016/j.vaccine.2016.06.020
   PubMed Web of Science ®Google Scholar
• Todryk SM, Walther M, Bejon P, Hutchings C, Thompson FM, Urban BC, Porter DW, Hill AV. Multiple functions of human T cells generated by experimental malaria challenge. Eur J Immunol 2009; 39(11):3042-51; PMID:19658096; https://doi.org/10.1002/eji.200939434
   PubMed Web of Science ®Google Scholar